Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data
Go back to Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 508.48 +8.75 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $499.73 | 52 Week High | $164.04 | |||
| Open | $502.29 | 52 Week Low | $97.52 | |||
| Day High | $509.54 | P/E | 92.96 | |||
| Day Low | $499.96 | EPS | $5.47 | |||
| Volume | 455,391 | |||||
